Fmoc-alpha-Me-L-Orn(Boc)-OH

Fmoc-alpha-Me-L-Orn(Boc)-OH is an Fmoc-protected, α-methylated L-ornithine derivative bearing a Boc-protected side-chain amine, providing orthogonally protected nucleophilic functionality for peptide chemistry. The molecule contains an Fmoc carbamate at the α-nitrogen, a free carboxylic acid for coupling at the C-terminus, and a second, Boc-protected primary amine on the ornithine side chain that can be selectively revealed for downstream derivatization. The α-methyl stereocenter imposes conformational bias relative to unmodified ornithine, which can influence amide bond geometry, backbone sterics, and intramolecular interactions during peptide assembly. The protected amine handles enable controlled reactivity under standard peptide synthesis conditions while maintaining compatibility with orthogonal deprotection strategies used to build amino acid sequences and functionalized side chains.

1. Peptide Synthesis

Fmoc-alpha-Me-L-Orn(Boc)-OH is used in solid-phase peptide synthesis and solution-phase peptide coupling as a protected amino acid building block where the Fmoc group directs α-amide formation after base-mediated Fmoc removal. The free carboxylic acid participates in standard coupling chemistry to generate the peptide backbone, while the Boc-protected side-chain amine on the ornithine residue remains masked to prevent side reactions during chain extension. The α-methyl substituent can be leveraged to tune local sterics and conformational preferences in peptide segments, supporting the construction of peptidic scaffolds that require controlled backbone geometry. Following selective Boc deprotection at the appropriate stage, the side-chain amine can be incorporated into further peptide modifications or cyclization motifs, enabling targeted peptide analog construction from a single orthogonally protected intermediate.

2. Side-Chain Functionalization

Fmoc-alpha-Me-L-Orn(Boc)-OH supports amino acid derivatization workflows where the Boc-protected ornithine side-chain amine serves as a protected handle for later functional group installation. The orthogonal protection pattern allows sequential operations, with Fmoc removal enabling backbone coupling while Boc retention preserves the side-chain nucleophile until deprotection. The resulting free primary amine can be converted into urea, amide, sulfonamide, carbamate, or alkylated derivatives, enabling attachment of linkers, affinity tags, or reactive groups for subsequent conjugation chemistry. The α-methyl stereochemistry can further modulate steric accessibility around the side chain, which may affect the outcome of functionalization and the properties of the resulting modified peptides or small-molecule conjugates.

3. Chemical Biology Conjugation

Fmoc-alpha-Me-L-Orn(Boc)-OH is applicable to chemical biology and biomolecule modification strategies that require controlled presentation of an amine-bearing amino acid residue for conjugation. The protected side-chain amine enables stepwise synthesis of peptide conjugates where the amine is revealed on demand to react with activated esters, isothiocyanates, aldehyde-derived linkers, or other electrophiles under mild conditions compatible with peptide-derived constructs. The Fmoc-protected α-amino functionality supports incorporation into defined peptide sequences, while the ornithine-derived side chain provides a primary amine for building multivalent labeling reagents or affinity reagents. Downstream, the α-methylated backbone residue can be used in molecular design to influence spacing and local conformation around the conjugation site, supporting the generation of well-defined chemical probes and structured labeling intermediates.

4. Protected Amino Acid Intermediate

Fmoc-alpha-Me-L-Orn(Boc)-OH serves as a chiral, orthogonally protected amino acid intermediate for fine chemical synthesis and process-oriented peptide intermediate preparation. The Fmoc carbamate and Boc-protected side-chain amine provide a protection strategy that separates α-functional group activation from side-chain nucleophile availability, supporting scalable manufacturing of protected amino acid derivatives and downstream coupling-ready intermediates. The presence of a stereogenic α-methyl center makes the compound useful for stereochemically defined building block design, enabling reproducible incorporation of α-methylated ornithine motifs into larger peptide and peptidomimetic frameworks. The carboxylic acid functionality allows conversion into activated derivatives for coupling steps or for generating additional protected forms used in industrial peptide building block supply chains.

5. Peptidomimetics And SAR Studies

Fmoc-alpha-Me-L-Orn(Boc)-OH can be employed in peptidomimetic construction and structure-activity relationship studies where ornithine-like side-chain functionality and α-methyl steric effects are used to probe sequence-dependent behavior. The protected amine enables introduction of charged or derivatized side chains that can participate in hydrogen bonding and electrostatic interactions after deprotection and functional group transformation. The α-methyl substitution provides a handle for designing constrained or sterically biased analogs, which can be incorporated into peptide fragments to evaluate how backbone modification impacts binding-site geometry and conformational preferences. The orthogonal protection scheme supports iterative synthesis of analog series, facilitating the preparation of stereochemically consistent derivatives for SAR mapping and mechanistic chemical studies.

1. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats

2. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

3. Olfactory receptor based piezoelectric biosensors for detection of alcohols related to food safety applications

4. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

5. High fat diet and GLP-1 drugs induce pancreatic injury in mice